Peter David Suzdak serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Peter David Suzdak has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 28, 2018 involved exercising options for 6,250 shares valued at $0.
Peter David Suzdak currently holds 22,250 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter David Suzdak has been a net neutral trader of RNN stock. They have purchased $0 and sold $0 worth of shares.
Peter David Suzdak's most recent insider trade was on Feb 28, 2018, when they sold 6,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.99 |
| Discretionary |
| Mar 18, 2016 | RNN | $19.2K | Award | 60,000 | $0.32 | Discretionary |